open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2020-07-08
Submitted: 2020-06-17
Accepted: 2020-07-01
Get Citation

Febuxostat ameliorates methotrexate-induced lung damage

S. M. Zaki, G. H.A. Hussein, H. M.A. Khalil, W. A. Abd Algaleel
DOI: 10.5603/FM.a2020.0075
·
Pubmed: 32644182

open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2020-07-08
Submitted: 2020-06-17
Accepted: 2020-07-01

Abstract

Background: The intention of the present study was to study the structural affection of the lung following Methotrexate (MTX) overdose. The proposed underlying mechanisms involved in lung affection were studied. The possible modulation role of febuxostat over such affection was studied.  

Materials and methods: 24 rats were divided into three groups: control, MTX-treated, febuxostat-treated. The study was continued for 2 weeks. Lung was processed for histological and immunohistochemical {Inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2)} studies. Inflammatory markers (TNF-α, IL-1), Western blot evaluation of NF-κB and oxidative/antioxidative markers were done.

Results: MTX-treated group exhibited inflammatory cellular infiltrations, thickened interalveolar septa, dilated congested blood vessels, extravasated blood, and apoptosis. The collagen fibers content increased 3-fold. MTX induced lung affection through oxidative stress (increase MDA /decrease GSH, SOD) and apoptosis. It induced sterile inflammation through increase NF-κB (two -fold), IL-1 (three-fold) and TNF-α (three-fold), COX-2 cells (2 ½-fold) and iNOS (6-fold).  With the use of febuxostat, the normal lung architecture was observed with a pit thickened interalveolar septum and extravasated blood. The collagen fibres content was minimal. Decrement of oxidative stress and sterile inflammation (COX-2 cells and iNOS were comparable to the control group. NF-κB, IL-1 and TNF-α became higher by 34, 64% and 100%).

Conclusions: The overdose of MTX displays inflammatory lung affection with residual fibrosis. It induces lung affection through oxidative stress, apoptosis and sterile inflammation. With the use of febuxostat, the normal lung architecture was preserved with a little structural affection or fibrotic residue. Febuxostat exerts its lung protection through its anti-inflammatory and antioxidant features.

Abstract

Background: The intention of the present study was to study the structural affection of the lung following Methotrexate (MTX) overdose. The proposed underlying mechanisms involved in lung affection were studied. The possible modulation role of febuxostat over such affection was studied.  

Materials and methods: 24 rats were divided into three groups: control, MTX-treated, febuxostat-treated. The study was continued for 2 weeks. Lung was processed for histological and immunohistochemical {Inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2)} studies. Inflammatory markers (TNF-α, IL-1), Western blot evaluation of NF-κB and oxidative/antioxidative markers were done.

Results: MTX-treated group exhibited inflammatory cellular infiltrations, thickened interalveolar septa, dilated congested blood vessels, extravasated blood, and apoptosis. The collagen fibers content increased 3-fold. MTX induced lung affection through oxidative stress (increase MDA /decrease GSH, SOD) and apoptosis. It induced sterile inflammation through increase NF-κB (two -fold), IL-1 (three-fold) and TNF-α (three-fold), COX-2 cells (2 ½-fold) and iNOS (6-fold).  With the use of febuxostat, the normal lung architecture was observed with a pit thickened interalveolar septum and extravasated blood. The collagen fibres content was minimal. Decrement of oxidative stress and sterile inflammation (COX-2 cells and iNOS were comparable to the control group. NF-κB, IL-1 and TNF-α became higher by 34, 64% and 100%).

Conclusions: The overdose of MTX displays inflammatory lung affection with residual fibrosis. It induces lung affection through oxidative stress, apoptosis and sterile inflammation. With the use of febuxostat, the normal lung architecture was preserved with a little structural affection or fibrotic residue. Febuxostat exerts its lung protection through its anti-inflammatory and antioxidant features.

Get Citation

Keywords

febuxostat, methotrexate, lung

About this article
Title

Febuxostat ameliorates methotrexate-induced lung damage

Journal

Folia Morphologica

Issue

Ahead of Print

Published online

2020-07-08

DOI

10.5603/FM.a2020.0075

Pubmed

32644182

Keywords

febuxostat
methotrexate
lung

Authors

S. M. Zaki
G. H.A. Hussein
H. M.A. Khalil
W. A. Abd Algaleel

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By  "Via Medica sp. z o.o." sp.k., Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl